Clarithromycin-13C,d3

Clarithromycin-13C,d3

• UNSPSC Description: Clarithromycin-13C,d3 is the deuterium and 13C labeled Clarithromycin[1].
• Target Antigen: Antibiotic; Autophagy; Bacterial; Cytochrome P450; Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Anti-infection;Autophagy;Metabolic Enzyme/Protease;Others
• Field of Research: Others
• Purity: 99.0
• Solubility: DMSO : 33.33 mg/mL (ultrasonic;warming)
• Smiles: O=C1[C@@H](C[C@](C)([C@@H]([C@H]([C@@H]([C@H](C(O[C@@H]([C@](C)([C@@H]([C@H]1C)O)O)CC)=O)C)O[C@]2(C[C@@](OC)([C@H]([C@@H](O2)C)O)C)[H])C)O[C@]3([C@@H]([C@H](C[C@H](O3)C)N([13C]([2H])([2H])[2H])C)O)[H])OC)C
• Molecular Weight: 751.96
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
• Shipping Conditions: Blue Ice
• Storage Conditions: -20°C, 3 years (Powder)
• Clinical Information: No Development Reported